PRELLIS IN THE MEDIA

Image-empty-state.png

Prellis Biologics Spring 2021 Newsletter

Prellis Biologics

March 17, 2021

Image-empty-state.png

Prellis Biologics, Inc. Generates 300 Human Antibodies That Bind the SARS-CoV2 Virus; Pursues Development of a Treatment and Preventative Therapy for COVID-19 Infection

Business Wire

May 19, 2020

Image-empty-state.png

Prellis Biologics Pursues Bioprinted Lymph Nodes for Production of COVID-19 Antibodies

3DPrint.com

May 7, 2020

Image-empty-state.png

3DHEALS Jenny Chen Interviews Gavan Wilhite: 3DHEALS2020 Software Design Interview

3DHEALS

April 23, 2020